The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index; 62 of the 97 sources its claims cite were checked for support.
Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces
Open accessAbstract
Among the emerging issues in probiotic safety, the possible presence of pks, a gene cluster synthetizing a genotoxin known as colibactin, is one of the most alarming. Indeed, indigenous E. coli strain pks-positive are found in 60% of patients with colorectal cancer, and the most widely used E. coli-based probiotic, known as E. coli Nissle 1917 (DSM 6601), is pks-positive. Starting from 25 potential candidates selected by screening 25 infant stool samples, we have selected an E. coli strain (named 5C, deposited as LMG S-33222) belonging to the phylotype A and having the serovar O173:H1. Having been previously completely sequenced by our group, we have further characterized this strain, demonstrating that it is devoid of the most known potential pathogenic-related genes, devoid of possible plasmids, antibiotic-sensitive according to the EFSA panel, resistant in gastric and enteric juice, significantly producing acetate, poorly producing histamine, endowed with a significant in vitro antipathogenic profile, promoting a significant in vitro immunological response based on IL-10 and IL-12, and devoid of the pks genes. A comparative genomics versus E. coli Nissle 1917 is also provided.
Overview
CoChat Summary
## TL;DR
The paper selects an infant-feces-derived *E. coli* strain, 5C (LMG S-33222), that is pks-negative and otherwise shows probiotic-like traits comparable to *E. coli* Nissle 1917. The authors argue that 5C may be a safer *E. coli*-based probiotic because it lacks the pks colibactin cluster while retaining resistance to gastric/intestinal conditions, anti-pathogen activity, and immunomodulatory effects.
## Key findings
- From 25 presumptive *E. coli* isolates recovered from fecal samples of 11 healthy children aged 3 months to 4 years, only 2 strains (5C and 8C) lacked the tested virulence-factor genes; 5C was chosen because 8C carried plasmids with putative virulence factors.
- Strain 5C was reported as antibiotic-sensitive according to EFSA probiotic guidelines and also susceptible to cefixime; its serovar was identified as O173:KNT:H1 and it belonged to phylogroup A.
- Genome analysis found 4,664 genes in 5C, with 4,357 coding sequences, no pks island genes, and no plasmids; a comparative analysis reported 3555 CDS shared with Nissle 1917, 744 CDS unique to 5C, and 82,332 variants versus Nissle 1917.
- In phenotype assays, 5C was said to survive simulated gastric and intestinal juices similarly to Nissle 1917, with higher tolerance at pH 1.8, significant antipathogenic activity against *K. pneumoniae*, *E. cloacae*, and both *S. enterica* serovars tested, and an ability to induce IL-10 and IL-12p70 in hPBMCs.
## Methods
- The study screened fecal samples from 11 healthy children (3 months to 4 years old), isolated 25 presumptive *E. coli* strains on TBX agar, confirmed species identity by 16S rRNA PCR, and removed strains carrying 13 virulence-factor genes before antibiotic testing.
- The selected strains were characterized by whole-genome sequencing, pks detection by BLAST/read mapping and PCR, comparative genomics versus Nissle 1917, prophage detection with PHASTEST, serotyping/phylotyping, and REP-PCR fingerprinting.
- Probiotic-feature assays included simulated gastric/intestinal survival, histamine release, acetate production, adhesion to HT29-MTX cells, antipathogenic co-culture assays, and hPBMC cytokine stimulation (IL-12p70 and IL-10).
## Limitations
- The paper does not report an in vivo efficacy or safety study in animals or humans for strain 5C; this is evident from the methods and results, which are limited to in vitro, genomic, and screening analyses.
- The text makes evident that only one non-pks strain (5C) was selected for deeper study, so conclusions about broader generalizability to other infant-derived *E. coli* isolates are limited; this is an inference from the reported sample and selection design.
- The authors note that pks-negative probiotic development remains an open area: they state that a modified pks-removed Nissle 1917 “has not yet been produced,” which underscores that their comparison is against an existing pks-positive probiotic rather than a finalized engineered alternative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
33 Valid · 10 Not valid · 17 Not checked · 72 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“the most widely used E. coli-based probiotic, known as E. coli Nissle 1917 (DSM 6601), is pks-positive.”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Abstract
What the sources say
- Not checked — no full text of the sourcecites [26] Sonnenborn U, Schulze J (2009) The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic. Microbial Ecology in Health and Disease 21:122–158. https://doi.org/10.3109/08910600903444267 source
- Not checked — no full text of the sourcecites [34] Arthur JC (2020) Microbiota and colorectal cancer: colibactin makes its mark. Nat Rev Gastroenterol Hepatol 17(6):317–318. https://doi.org/10.1038/s41575-020-0303-y source
- Not checked — no full text of the sourcecites [35] Pleguezuelos-Manzano C, Puschhhof J, Rosendah Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, Paganelli FL, Geurts MH, Beumer J, Mizutani T, Miao Y, van der Linden R, van der Elst S, Genomics England Research Consortium, Garcia KC, Top J, Willems RJL, Giannakis MH, Bonnet R, Quirke P, Meyerson M, Cuppen E, van Boxtel H, Clevers H (2020) Mutational signature in colorectal cancer caused by genotoxic pks+ E coli. Nature 580(7802):269–273. https://doi.org/10.1038/s41586-020-2080-8 source
- Could not verifycites [36] Chen B, Ramazzotti D, Heide T, Spiteri I, Fernandez-Mateos J, James C, Magnani L, Graham TA, Sottoriva A (2023) Contribution of pks+ E. coli mutations to colorectal carcinogenesis. Nat Commun 14(1):7827. https://doi.org/10.1038/s41467-023-43329-5 sourceExperimental — accuracy not yet measured
The Introduction says some E. coli strains carry the pks island, and the Results section on pks+ genomic DNA reports detecting pks genes in patient samples. Neither identifies E. coli Nissle 1917 or DSM 6601 as pks-positive; searches for Nissle, DSM 6601, and probiotic did not find a passage establishing that claim. (LLM, conf=0.76)
- Could not verifycites [37] Sogari A, Rovera E, Grasso G, Mariella E, Reilly NM, Lamba S, Mauri G, Durinikova E, Vitiello PP, Lorenzato A, Avolio M, Piumatti E, Bonoldi E, Aquilano MC, Arena S, Sartore-Bianchi A, Siena S, Trusolino L, Donalisio M, Russo M, Di Nicolantonio F, Lembo D, Bardelli A (2024) Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells. Cell Rep Med 5(2):101376. https://doi.org/10.1016/j.xcrm.2023.101376 sourceExperimental — accuracy not yet measured
The Introduction says that some E. coli strains harbor the pks island, but does not identify Nissle 1917 as one of them. The References list a paper about the genotoxic activity of Nissle 1917, while the Methods identify a different experimental strain, DH10B pBeloBAC-pks. Searches for Nissle 1917 and DSM 6601 found no passage in our copy stating that Nissle 1917 is pks-positive. (LLM, conf=0.75)
- Could not verifycites [38] Terlouw D, Boot A, Ducarmon QR, Nooij S, Suerink M, van Leerdam ME, van Egmond D, Tops CM, Zwittink RD, Ruano D, Langers AMJ, Nielsen M, van Wezel T, Morreau H (2024) Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients. BMC Cancer 24(1):104. https://doi.org/10.1186/s12885-024-11849-y sourceExperimental — accuracy not yet measured
The Background discusses pks-bearing E. coli generally, and the Results report pks genes in patient fecal samples. Neither identifies E. coli Nissle 1917 as pks-positive. Searches for “Nissle 1917” and “DSM 6601” found no passage addressing that strain. (LLM, conf=0.75)
- Supportedcites [39] Rosendahl Huber A, Pleguezuelos-Manzano C, Puschhof J, Ubels J, Boot C, Saftien A, Verheul M, Trabut LT, Groenen N, van Roosmalen M, Ouyang KS, Wood H, Quirke P, Meijer G, Cuppen E, Clevers H, van Boxtel R (2024) Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell 42(3):487-496.e6. https://doi.org/10.1016/j.ccell.2024.02.009 source
The Introduction explicitly states that E. coli Nissle 1917 (EcN) harbors the pks operon in its genome. The Results also include EcN in a panel of pks-positive E. coli strains. Page numbers are not provided in our copy. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“All of them were confirmed to belong to E. coli species by species-specific PCR [50].”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Results > Species-Specific Identification, Pathogenetic Characterization and Antibiotic Sensitivity Profiles
What the sources say
- Could not verifycites [50] da Silva TF, Glória RA, de Sousa TJ, Americo MF, Freitas ADS, Viana MVC, de Jesus LCL, da Silva Prado LC, Daniel N, Ménard O, Cochet MF, Dupont D, Jardin J, Borges AD, Fernandes SOA, Cardoso VN, Brenig B, Ferreira E, Profeta R, Aburjaile FF, de Carvalho RDO, Langella P, Le Loir Y, Cherbuy C, Jan G, Azevedo V, Guédon É (2023) Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain. BMC Microbiol 23(1):364. https://doi.org/10.1186/s12866-023-03112-4 sourceExperimental — accuracy not yet measured
The Methods (In silico analysis; no page given) describe two E. coli strains used in this study and genomic analysis, not 25 recovered presumptive isolates. Searches for species-specific PCR and isolate identification found no passage confirming that all 25 strains were identified by that method; the paper's RT-qPCR assay addresses a different purpose. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“(iii) antibiotic-sensitive according to the EFSA panel”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Abstract
What the sources say
- Could not verifycites [66] European Food Safety Authority (EFSA) (2012) Panel on additives and products or substances used in animal feed (FEEDAP) guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J 10:2740–2750. https://doi.org/10.2903/j.efsa.2012.2740 sourceExperimental — accuracy not yet measured
Section 1.1 defines how the FEEDAP Panel classifies strains as susceptible or resistant using antimicrobial cut-off values. The passages do not assess E. coli 5C specifically; searches for “E. coli 5C” and “Escherichia coli 5C” found no such assessment in our copy. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“versus cefixime, a representative of the cephalosporin class not included in the EFSA panel, the strains resulted to be susceptible according to a set cut-off recently demonstrated [112].”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Results > Species-Specific Identification, Pathogenetic Characterization and Antibiotic Sensitivity Profiles
What the sources say
- Could not verifycites [112] Zaragoza G, Pérez-Vázquez M, Villar-Gómara L, González-Prieto A, Oteo-Iglesias J, Alós JI (2024) Community emergence of cefixime-resistant Escherichia coli belonging to ST12 with chromosomal AmpC hyperproduction. Antibiotics (Basel) 13(3):218. https://doi.org/10.3390/antibiotics13030218 sourceExperimental — accuracy not yet measured
Section 2.5 reports that the paper’s 23 E. coli isolates were resistant to cefixime; it does not report results for strains 5C, 8C, or Nissle 1917. Section 3.2 says susceptibility was interpreted using existing EUCAST breakpoints, not a newly demonstrated cefixime cut-off. The cited paper therefore cannot verify the susceptibility claim for those strains. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Scientific literature has shown that between 27 and 33% of E. coli detectable in the feces of European newborns are pks-positive [136–138].”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Discussion > Selection of a Probiotic E. coli Strains Not-Releasing Colibactin
What the sources say
- Not checked — no full text of the sourcecites [136] Nowrouzian F, Hesselmar B, Saalman R, Strannegard IL, Aberg N, Wold AE, Adlerberth I (2003) Escherichia coli in infants’ intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 54(1):8–14. https://doi.org/10.1203/01.PDR.0000069843.20655.EE source
- Supportedcites [137] Faïs T, Delmas J, Barnich N, Bonnet R, Dalmasso G (2018) Colibactin: more than a new bacterial toxin. Toxins (Basel) 10(4):151. https://doi.org/10.3390/toxins10040151 source
Section 2.1, “Escherichia coli,” reports that 33% of fecal E. coli tested from Swedish newborns carried the pks island, as did 26.9% of fecal E. coli isolates from healthy French neonates. Rounding 26.9% to 27% supports the stated range. (LLM, conf=0.94)
- Partly supportedcites [138] Secher T, Brehin C, Oswald E (2016) Early settlers: which E. coli strains do you not want at birth? Am J Physiol Gastrointest Liver Physiol 311(1):G123-9. https://doi.org/10.1152/ajpgi.00091.2016 sourceExperimental — accuracy not yet measured
The section ‘Colibactin-Producing E. coli, the Thin Red Line Between Commensalism and Pathogenesis’ (page unavailable) reports pks-positive E. coli colonization in Swedish and French infants at birth. It gives rates of up to 18% and 15% of infants, respectively—not 27–33% of E. coli detected in newborn feces. The populations and denominator therefore do not support the claimed percentage. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims · 9 with their cited sources checked
Create a free account to see all 132 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 33
- The quote only partly states this claim. 1
- Not yet classified. 1
Citations
Cites
fastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721 · cited 1×
“1 [81].”
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987 · cited 1×
“DNA extraction, library preparation, and in silico genome analysis were performed on the strains according to methods elsewhere described [67–76].”
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
BLAST+: architecture and applications
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-421 · Cited by 22,074
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Prodigal: prokaryotic gene recognition and translation initiation site identification
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-119 · Cited by 12,587
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
QUAST: quality assessment tool for genome assemblies
Gurevich, A., Saveliev, V., Vyahhi, N., & Tesler, G. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt086 · Cited by 11,172
GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database
Chaumeil, P.-A., Mussig, A. J., Hugenholtz, P., & Parks, D. H. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz848 · Cited by 5,259
Huerta-Cepas, J., Szklarczyk, D., Heller, D., Hernández-Plaza, A., Forslund, S. K., Cook, H., Mende, D. R., Letunic, I., Rattei, T., Jensen, L. J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1085 · Cited by 4,902 · cited 1×
“Then, the CDS overlapping any RNA genes were deleted, as they are usually false positive calls [98].”
Research works printed but not linked: 3
- Joffré E, Sjöling Å (2016) The LT1 and LT2 variants of the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) are associated with major ETEC lineages. Gut Microbes 7(1):75–81. https://doi.org/10.1080/19490976.2015.1127480.Erratum.In:doi:10.1128/JB.02050-14 · doi:10.1080/19490976.2015.1127480.erratum.in:doi:10.1128/jb.02050-14
- Farshad S, Emamghoraishi F, Japoni A (2010) Association of virulent genes hly, sfa, cnf-1 and pap with antibiotic sensitivity in Escherichia coli strains isolated from children with community-acquired UTI. Iran Red Crescent Med J 12:33–37
- Wickham H, Chang W, Henry L, Pedersen TL, Takahashi K, Wilke C, Dunnington D. (2023). RStudio Ggplot2: create elegant data visualisations using The grammar of graphics; 2021. URL https://CRAN.R-project.org/package=ggplot2. R package version, 3(5), 233.
Cited by
Pierro, F. D., Thacharodi, A., Kumaraswami, M., Suvorov, A. N., Zupet, J., & Zerbinati, N. (2026) · Microbial Cell Factories · doi:10.1186/s12934-026-02997-w · Cited by 10
Self-citationBertuccioli, A., Sisti, D., Lazzerini, N., Palazzi, C. M., Zonzini, G. B., Ragazzini, M., & Belli, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1604319 · Cited by 6
Self-citationStrain-level resolution is needed to understand the putative pathogenic role of bacteria
Pierro, F. D., Palazzi, C. M., Bertuccioli, A., et al. (2025) · Minerva Medica · doi:10.23736/s0026-4806.25.09792-7
Self-citationHe, Y., 李廷慧, Sun, H., & Yang, J. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05023-0
Xu, J., Shi, T., Qian, D., Cheng, K., Xu, P., 陈学年, Wang, C., Ru, N., Li, T., Ma, N., et al. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.09.052
Metadata
- Authors
- Di Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., Palazzi, C. M., Tanda, M. L., & Zerbinati, N.
- Affiliations
- Velleja Research (IT)
- University of Urbino (IT)
- Ospedale Misericordia - Grosseto (IT)
- Ospedale Koelliker (IT)
- University of Insubria (IT)
- Corresponding author
- Palazzi, Chiara Maria
- ORCID
- Venue
- Probiotics and Antimicrobial Proteins
- Published
- 2025-04-16
- Volume
- 18
- Issue
- 1
- Pages
- 436-456
- ISSN
- 1867-1306 (ISSN-L)
- 1867-1314
- PMC
- PMC12999690
- OpenAlex
- W4409506837
- Cited by
- 5
- References
- 151
- Citations by year
- 2026: 3 · 2025: 2
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Probiotics and Antimicrobial Proteins (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion, cc-by)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- colibactin, probiotic safety, comparative genomics, acetate production, histamine synthesis, antipathogenic activity, IL-10, IL-12, alpha-hemolysin, cytotoxic necrotizing factor 1, probiotic strain selection
- MeSH terms
- Escherichia coli, Feces, Humans, Infant, Peptides, Probiotics, Genomics, Escherichia coli Proteins, Polyketides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces. https://app.cochat.ai/papers/10.1007/s12602-025-10522-5
- The paper
- Di Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., Palazzi, C. M., Tanda, M. L., & Zerbinati, N. (2026). Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10522-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.